- Report
- February 2024
- 175 Pages
Global
From €4828EUR$5,000USD£4,088GBP
- Report
- September 2023
- 145 Pages
Global
From €2413EUR$2,499USD£2,043GBP
- Report
- May 2024
- 164 Pages
Global
From €5262EUR$5,450USD£4,456GBP
- Report
- January 2024
- 200 Pages
Global
From €4007EUR$4,150USD£3,393GBP
- Report
- June 2023
- 158 Pages
Global
From €2414EUR$2,500USD£2,044GBP
- Report
- September 2023
- 124 Pages
North America
From €2606EUR$2,699USD£2,207GBP
- Report
- March 2024
- 194 Pages
Global
From €3258EUR$3,374USD£2,759GBP
€3620EUR$3,749USD£3,065GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1931EUR$2,000USD£1,635GBP
- Report
- October 2023
- 186 Pages
Global
From €5310EUR$5,500USD£4,497GBP
- Report
- March 2024
- 181 Pages
Global
From €3258EUR$3,374USD£2,759GBP
€3620EUR$3,749USD£3,065GBP
- Report
- March 2024
- 186 Pages
Global
From €3258EUR$3,374USD£2,759GBP
€3620EUR$3,749USD£3,065GBP
- Report
- October 2023
- 75 Pages
Global
From €5745EUR$5,950USD£4,865GBP
- Report
- March 2024
- 195 Pages
Global
From €3258EUR$3,374USD£2,759GBP
€3620EUR$3,749USD£3,065GBP
- Report
- January 2024
- 150 Pages
Global
From €4683EUR$4,850USD£3,965GBP
- Report
- October 2023
- 185 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1448EUR$1,500USD£1,226GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1931EUR$2,000USD£1,635GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1931EUR$2,000USD£1,635GBP
- Drug Pipelines
- April 2024
- 50 Pages
Global
From €1448EUR$1,500USD£1,226GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1207EUR$1,250USD£1,022GBP
The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more